BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30947302)

  • 1. A call to arms: Mustering secondary metabolites for success and survival of an opportunistic pathogen.
    Raffa N; Keller NP
    PLoS Pathog; 2019 Apr; 15(4):e1007606. PubMed ID: 30947302
    [No Abstract]   [Full Text] [Related]  

  • 2. Some fungi in the air. Interview by Sophia Häfner.
    Cramer RA; Hohl TM
    Microbes Infect; 2013 Apr; 15(4):255-8. PubMed ID: 23376622
    [No Abstract]   [Full Text] [Related]  

  • 3. New insights into invasive aspergillosis--from the pathogen to the disease.
    Binder U; Lass-Flörl C
    Curr Pharm Des; 2013; 19(20):3679-88. PubMed ID: 23278533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspergillus fumigatus: contours of an opportunistic human pathogen.
    McCormick A; Loeffler J; Ebel F
    Cell Microbiol; 2010 Nov; 12(11):1535-43. PubMed ID: 20716206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis at the mold-host interface: a potential key to understanding and treating invasive aspergillosis.
    Ben-Ami R
    Future Microbiol; 2013 Nov; 8(11):1453-62. PubMed ID: 24199803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Causative Agents of Aspergillosis Including Cryptic Aspergillus Species and A. fumigatus].
    Toyotome T
    Med Mycol J; 2016; 57(4):J149-J154. PubMed ID: 27904060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elastin increases biofilm and extracellular matrix production of Aspergillus fumigatus.
    Brandão ISL; Oliveira-Moraes HMDS; Souza Motta CM; Oliveira NT; Magalhães OMC
    Braz J Microbiol; 2018; 49(3):675-682. PubMed ID: 29452851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspergillus chevalieri (Mangin) Thom and Church: a new opportunistic pathogen of human cutaneous aspergillosis.
    Naidu J; Singh SM
    Mycoses; 1994; 37(7-8):271-4. PubMed ID: 7739658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive subglottal aspergillosis in a patient with severe aplastic anemia: a case report.
    Nagasawa M; Itoh S; Tomizawa D; Kajiwara M; Sugimoto T; Kumagai J
    J Infect; 2002 Apr; 44(3):198-201. PubMed ID: 12099752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper Utilization, Regulation, and Acquisition by
    Raffa N; Osherov N; Keller NP
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism.
    Schaffner A; Böhler A
    Mycoses; 1993; 36(11-12):421-4. PubMed ID: 7935575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease.
    Sallmann S; Heilmann A; Heinke F; Kerkmann ML; Schuppler M; Hahn G; Gahr M; Rösen-Wolff A; Roesler J
    Pediatr Infect Dis J; 2003 Feb; 22(2):199-200. PubMed ID: 12613459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative systems analysis of the secretome of the opportunistic pathogen Aspergillus fumigatus and other Aspergillus species.
    Vivek-Ananth RP; Mohanraj K; Vandanashree M; Jhingran A; Craig JP; Samal A
    Sci Rep; 2018 Apr; 8(1):6617. PubMed ID: 29700415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Aspergillus presenting with visual symptoms.
    Telander DG; Pambuccian SE; Olsen TW
    Retina; 2004 Feb; 24(1):166-8. PubMed ID: 15076964
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous aspergillosis as a first manifestation of systemic infection in allogeneic haematopoietic stem cell transplantation.
    Hashmi KU; Ahmed P; Satti TM; Raza S; Chaudhry QU; Ikram A; Kamal MK; Akhtar FM
    J Pak Med Assoc; 2007 Jun; 57(6):324-6. PubMed ID: 17629239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triazole fungicides and the selection of resistance to medical triazoles in the opportunistic mould Aspergillus fumigatus.
    Verweij PE; Kema GH; Zwaan B; Melchers WJ
    Pest Manag Sci; 2013 Feb; 69(2):165-70. PubMed ID: 23109245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Azole-resistant invasive aspergillosis].
    van der Linden JW; Warris A; van der Meer JW; Bresters D; Melchers WJ; Verweij PE
    Ned Tijdschr Geneeskd; 2009; 153():A765. PubMed ID: 20051169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
    Snelders E; Melchers WJ; Verweij PE
    Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus.
    Denes E; Pichon N; Debette-Gratien M; Bouteille B; Gaulier JM
    Clin Infect Dis; 2004 Aug; 39(4):603-4. PubMed ID: 15356837
    [No Abstract]   [Full Text] [Related]  

  • 20. Intercountry Transfer of Triazole-Resistant Aspergillus fumigatus on Plant Bulbs.
    Dunne K; Hagen F; Pomeroy N; Meis JF; Rogers TR
    Clin Infect Dis; 2017 Jul; 65(1):147-149. PubMed ID: 28369271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.